Merck Sharp & Dohme Corp. v. Ajanta Pharma Limited et al
| Merck Sharp & Dohme Corp. |
| Ajanta Pharma Limited and Ajanta Pharma USA Inc. |
| 1:2020cv01496 |
| November 4, 2020 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 30, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 18 NOTICE OF SERVICE of Plaintiff's Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs Asserted Patents filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
Filing 17
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/12/2021. Amended Pleadings due by 3/12/2021. Fact Discovery completed by 3/12/2021. A Pretrial Conference is set for 9/10/2021, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 10/4/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 12/28/2020. Associated Cases: 1:19-md-02902-RGA, 1:20-cv-01496-RGA(nms)
|
| Filing 16 Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esq. , regarding certificate of correction. (Silver, Daniel) Modified on 12/23/2020 (nms). |
| Filing 15 PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 12/22/2020 (nms). |
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney David B. Abramowitz and Carolyn A. Blessing - filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. (Attachments: #1 Abramowitz Pro Hac Certification, #2 Blessing Pro Hac Certification)(Bilson, David) |
|
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney David B. Abramowitz and Carolyn A. Blessing, filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. Signed by Judge Richard G. Andrews on 12/2/2020. (nms)
|
| Pro Hac Vice Attorneys Michael J. Gaertner and Christopher J. Cassella for Ajanta Pharma Limited and Ajanta Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
|
SO ORDERED, re #13 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner and Christopher J. Cassella, filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. Signed by Judge Richard G. Andrews on 12/1/2020. (nms)
|
| Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner and Christopher J. Cassella - filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. (Attachments: #1 Certification, #2 Certification)(Bilson, David) Modified on 12/1/2020 (nms). |
| Filing 12 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ajanta Pharma Limited. (Phillips, John) |
| Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ajanta Pharma Limited for Ajanta Pharma USA Inc. filed by Ajanta Pharma USA Inc.. (Phillips, John) |
| Filing 10 ANSWER to #1 Complaint and Affirmative Defenses, by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Phillips, John) Modified on 11/25/2020 (nms). |
|
Filing 9
SO ORDERED Granting Stipulation and Proposed Order Regarding Authenticity of Documents. Signed by Judge Richard G. Andrews on 11/23/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms)
|
| Filing 8 STIPULATION and Proposed Order Regarding Authenticity of Documents, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/23/2020 (nms). |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 7 DECLARATION of Service, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/12/2020 (nms). |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (kmd) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. - filed by Merck Sharp & Dohme Corp. (kmd) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (kmd) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: no earlier than 10/5/2020. Date of Expiration of Patent: 11/24/2026.Thirty Month Stay Deadline: no earlier than 4/5/2023. (kmd) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Filing 1 COMPLAINT filed against Ajanta Pharma Limited, Ajanta Pharma USA Inc. - Magistrate Consent Notice to Pltf. (Filing fee $400, receipt number ADEDC-3311422.) - filed by Merck Sharp & Dohme Corp. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(kmd) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
